http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Examines legislative proposals to promote the development of bioterrorism countermeasures by private companies, including Project BioShield, a proposal to encourage development of vaccines and treatments for potential bioterrorism agents such as anthrax and smallpox. Describes provisions of P.L. 108-276, the Project BioShield Act of 2004, including appropriations and acquisitions; and reviews policy issues.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
Library of Congress. Congressional Research Service.